CRISPR-mediated correction of skeletal muscle Ca <sup>2+</sup> handling in a novel DMD patient-derived pluripotent stem cell model
Cristina Morera(Queen Mary University of London), Yung‐Yao Lin(Queen Mary University of London)
Cited by 0
Related Papers
Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC-derived neural stem cells in glioblastoma
|Nature Communications|2021|34
A new patient‐derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α‐dystroglycan
|EMBO Reports|2019|23
Optogenetic modeling of human neuromuscular circuits in Duchenne muscular dystrophy with CRISPR and pharmacological corrections
|Science Advances|2021|19
CRISPR-mediated correction of skeletal muscle Ca2+ handling in a novel DMD patient-derived pluripotent stem cell model
|Neuromuscular Disorders|2022|5
Targeted gene correction of <i>FKRP</i> by CRISPR/Cas9 restores functional glycosylation of α-dystroglycan in cortical neurons derived from human induced pluripotent stem cells
|bioRxiv (Cold Spring Harbor Laboratory)|2017|0